Thryv Holdings recently saw its consensus analyst price target fall significantly, dropping from $19.50 to $13.00. This notable decline comes as experts reassess the company’s near-term prospects in ...

Thryv® Holdings, Inc. (NASDAQ:THRY), provider of the leading small business marketing and sales software platform, has launched a tailored growth marketing solution for home services businesses ...

Thryv® (NASDAQ: THRY), Australia and New Zealand’s provider of the leading small business marketing and sales software platform, has announced a new partnership with Physiotherapy New Zealand (PNZ), ...

MONTREAL, Nov. 5, 2025 /CNW/ – Thryv Therapeutics Inc., a clinical-stage biotechnology company advancing a series of novel ...

Thryv Therapeutics Inc., a clinical-stage biotechnology company advancing a series of novel serum glucocorticoid inducible kinase 1 (SGK1) inhibitors for ...

Q3 2025 Earnings Call Transcript October 30, 2025 Thryv Holdings, Inc. misses on earnings expectations. Reported EPS is $0.23 ...

Hundreds of small business owners and entrepreneurs gathered in Scottsdale last month to talk strategy at the Grow2025 ...

Thryv Holdings, Inc. ("Thryv" or the "Company"), the provider of Thryv®, the leading small business marketing and sales software platform, reported an increase in SaaS revenue of 33% year-over-year in ...

Full year SaaS revenue guidance is now $460 million to $463 million, narrowed from Q2's $460 million to $465 million range. SaaS adjusted EBITDA guidance increased from $70.5 million-$73.5 million in ...

Thryv Holdings, Inc. stock dips on slowed growth, but management targets strong SaaS revenue by 2030. Click for more on THRY stock prospects.

Amid global market volatility, TipRanks offers valuable tools to guide investors. One of the most powerful is the Smart Score ...

This commitment is quantifiable: 62 percent of small businesses expect to spend at least $1,000 on AI in the coming year, ...